Cilnidipine is a novel, effective, and safe CCB that inhibits L-type and N-type calcium channels, regulating cardiac function. It is recommended for combination therapy in diabetic hypertensive patients to reduce cardiovascular and renal risks. ARBs, like telmisartan and losartan, are effective in reducing cardiovascular risk factors and renal complications. Cilnidipine's reno-protective and cardioprotective benefits make it the preferred choice for hypertensive patients with diabetes. Listen to the expert to know more on the Cilnidipine + ARB for Diabetic Hypertensives .